Viatris VTRS
NASDAQ VTRS
$16.45 -0.16 (-0.93%)
As of: Sep 9, 2026 · 3:08 PM EDT

Viatris (VTRS) Liabilities from Discontinued Operations (2022 - 2024)

Viatris (VTRS) posted Liabilities from Discontinued Operations of $32.8 million for Q2 2024, down 86.03% on a QoQ basis from $234.8 million in Q1 2024.

Analysis

Viatris (VTRS) Liabilities from Discontinued Operations (2022 - 2024) Analysis & Trends

Viatris has reported Liabilities from Discontinued Operations for 3 years, with the latest figure at $32.8 million in Q2 2024.

  • On a quarterly basis, Liabilities from Discontinued Operations changed N/A year-over-year to $32.8 million in Q2 2024; TTM through Jun 2024 was $32.8 million, a N/A change from a year earlier, with the FY2023 full-year figure at $275.1 million, changed N/A from the prior year.
  • Liabilities from Discontinued Operations was $32.8 million for Q2 2024 at Viatris, down from $234.8 million in the prior quarter.
  • The five-year high for Liabilities from Discontinued Operations was $335.3 million in Q3 2022, with the low at $14.3 million in Q3 2023.
  • Average Liabilities from Discontinued Operations over 3 years is $207.9 million, with a median of $275.1 million recorded in 2023.
  • The largest YoY upside for Liabilities from Discontinued Operations was 95.74% in 2023 against a maximum downside of 95.74% in 2023.
  • Over 3 years, Liabilities from Discontinued Operations stood at $335.3 million in 2022, then retreated by 17.95% to $275.1 million in 2023, then plunged by 88.08% to $32.8 million in 2024.
  • The last three Liabilities from Discontinued Operations figures came in at $32.8 million (Q2 2024), $234.8 million (Q1 2024), and $275.1 million (Q4 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.53 Bn 38.88 Bn 2.15 Bn
2 Viatris 19.14 Bn 18.25 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.86 Bn 9.69 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.45 Bn 5.33 Bn 334.51 Mn
5 Bausch Health Companies 2.33 Bn 492.63 Mn 2.10 Bn
6 Alvotech 1.51 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.48 Bn 1.12 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 992.90 Mn 702.78 Mn 93.47 Mn
9 Fennec Pharmaceuticals 400.20 Mn 358.95 Mn 17.15 Mn
10 RedHill Biopharma 178.79 Mn 178.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 32.80 Mn
Mar 31, 2024 234.80 Mn
Dec 31, 2023 275.10 Mn
Sep 30, 2023 14.30 Mn
Sep 30, 2022 335.30 Mn
Jun 30, 2022 285.10 Mn
Mar 31, 2022 277.70 Mn